Last reviewed · How we verify
Reduction of risk of upper gastrointestinal bleeding
Approved treatments
- Golytely · Abbott
Golytely works by neutralizing stomach acid and helping to protect the stomach lining. - Prilosec · AstraZeneca (originally Astra AB)
Irreversibly inhibits the hydrogen-potassium ATPase (proton pump) in gastric parietal cells, potently suppressing stomach acid secretion. - Omeprazol · RenJi Hospital
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Reduction of risk of upper gastrointestinal bleeding patent landscape — cliff calendar, originator estates, attackable patents
- Reduction of risk of upper gastrointestinal bleeding treatment landscape brief
- Reduction of risk of upper gastrointestinal bleeding treatment updates RSS
Frequently asked questions about Reduction of risk of upper gastrointestinal bleeding
What drugs treat Reduction of risk of upper gastrointestinal bleeding?
Tracked treatments include Golytely, Prilosec, Omeprazol.
What is the treatment for Reduction of risk of upper gastrointestinal bleeding?
Standard treatment for Reduction of risk of upper gastrointestinal bleeding includes Golytely, Prilosec, Omeprazol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Reduction of risk of upper gastrointestinal bleeding patent cliff · Reduction of risk of upper gastrointestinal bleeding CI report
- Treatment: Golytely · Abbott
- Treatment: Prilosec · AstraZeneca (originally Astra AB)
- Treatment: Omeprazol · RenJi Hospital
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing